{"id":{"repo_id":"usf","oai_identifier":"oai:digitalcommons.usf.edu:etd-12068"},"canonical_url":"https://search.ndltd.org/etd/usf/oai:digitalcommons.usf.edu:etd-12068","repository":{"repo_id":"usf","name":"University of South Florida","base_url":"https://digitalcommons.usf.edu/do/oai/"},"display":{"title":"Development and application of γ-AA peptide on enzyme mimetic and biomolecular agents","abstract":"This dissertation investigates the multifaceted utility of γ-AA peptides in various biological contexts, highlighting their capability in mimicking bioactive proteins, facilitating novel drug discovery, and obstructing protein-protein interactions. Initially, we introduced the design of an ingenious γ-AA peptide scaffold that replicates the hydrolysis capabilities of natural enzymes, with the intention to overcome their stability limitations. Notably, the designed catalyst exhibited excellent esterase activity with the coordination of Zn2+. Subsequently, optimization of a linear γ-AA peptide compound through a dimeric strategy resulted in P3-1, a potent inhibitor of amyloid-β 42. Evidenced by both in vivo and in vitro experiments, its potential for contributing to the early detection and treatment of Alzheimer's Disease was demonstrated. Furthermore, the investigation of cyclic γ-AA peptide library was pursued as an efficient strategy for uncovering bioactive molecules. Two compounds, P4-1, and P4-2, identified from the macrocyclic combinatorial library, displayed a remarkable binding affinity towards Prostaglandin E2 receptor 2, marking a significant stride towards the development of potential therapeutics.","abstract_html":"This dissertation investigates the multifaceted utility of γ-AA peptides in various biological contexts, highlighting their capability in mimicking bioactive proteins, facilitating novel drug discovery, and obstructing protein-protein interactions. Initially, we introduced the design of an ingenious γ-AA peptide scaffold that replicates the hydrolysis capabilities of natural enzymes, with the intention to overcome their stability limitations. Notably, the designed catalyst exhibited excellent esterase activity with the coordination of Zn2+. Subsequently, optimization of a linear γ-AA peptide compound through a dimeric strategy resulted in P3-1, a potent inhibitor of amyloid-β 42. Evidenced by both in vivo and in vitro experiments, its potential for contributing to the early detection and treatment of Alzheimer&#x27;s Disease was demonstrated. Furthermore, the investigation of cyclic γ-AA peptide library was pursued as an efficient strategy for uncovering bioactive molecules. Two compounds, P4-1, and P4-2, identified from the macrocyclic combinatorial library, displayed a remarkable binding affinity towards Prostaglandin E2 receptor 2, marking a significant stride towards the development of potential therapeutics.","abstract_has_math":false,"creators":["Gu, Meng"],"institution":"University of South Florida","degree_name":"Doctor of Philosophy (Ph.D.)","degree_level":"Dissertation","degree_discipline":"Chemistry","degree_department":null,"school":null,"contributors":["Jianfeng Cai, Ph.D.","Feng Cheng, Ph.D.","Kirpal Bisht, Ph.D.","Wayne Guida, Ph.D."],"advisors":[],"committee_chairs":[],"committee_members":[],"year":2023,"date_issued":"2023-06-29T07:00:00Z","date_published":"2023-06-29T07:00:00Z","updated_at":"2026-11-19T08:50:05Z","subjects":["Enzyme-like catalyst","Hydrolysis","Alzheimer’s disease","Aβ inhibition","macrocyclic combinatorial library","Chemistry"],"languages":[],"rights":[],"rights_urls":[],"identifier_entries":[],"person_identifier_entries":[]},"links":{"outbound_url":"https://digitalcommons.usf.edu/etd/10781","outbound_label":"Repository record","outbound_source":"dc:identifier","record_url":"https://digitalcommons.usf.edu/etd/10781","record_label":"Repository record","record_kind":"record","record_source":"dc:identifier","download_url":null,"download_label":null,"download_source":null,"access_status":null,"embargo_until":null,"access_note":null},"source_record":{"url":"https://digitalcommons.usf.edu/do/oai/?verb=GetRecord&metadataPrefix=oai_etdms&identifier=oai%3Adigitalcommons.usf.edu%3Aetd-12068","prefix":"oai_etdms"},"metadata_groups":[{"id":"people","label":"People","entries":[{"key":"dc:contributor","label":"Contributor","values":["Jianfeng Cai, Ph.D.","Feng Cheng, Ph.D.","Kirpal Bisht, Ph.D.","Wayne Guida, Ph.D."]},{"key":"dc:creator","label":"Author","values":["Gu, Meng"]}]},{"id":"academic_context","label":"Academic Context","entries":[{"key":"dc:date","label":"Dc Date","values":["2023-06-29T07:00:00Z"]},{"key":"thesis:degree_discipline","label":"Discipline","values":["Chemistry"]},{"key":"thesis:degree_level","label":"Degree Level","values":["Dissertation","Ph.D."]},{"key":"thesis:degree_name","label":"Degree Name","values":["Doctor of Philosophy (Ph.D.)"]},{"key":"thesis:institution_name","label":"Thesis Institution Name","values":["University of South Florida"]}]},{"id":"subjects_keywords","label":"Subjects and Keywords","entries":[{"key":"dc:subject","label":"Dc Subject","values":["Enzyme-like catalyst","Hydrolysis","Alzheimer’s disease","Aβ inhibition","macrocyclic combinatorial library","Chemistry"]}]},{"id":"identifiers","label":"Identifiers","entries":[{"key":"dc:identifier","label":"Identifier","values":["https://digitalcommons.usf.edu/etd/10781"]}]},{"id":"additional","label":"Additional Metadata","entries":[{"key":"dc:description","label":"Description","values":["This dissertation investigates the multifaceted utility of γ-AA peptides in various biological contexts, highlighting their capability in mimicking bioactive proteins, facilitating novel drug discovery, and obstructing protein-protein interactions. Initially, we introduced the design of an ingenious γ-AA peptide scaffold that replicates the hydrolysis capabilities of natural enzymes, with the intention to overcome their stability limitations. Notably, the designed catalyst exhibited excellent esterase activity with the coordination of Zn2+. Subsequently, optimization of a linear γ-AA peptide compound through a dimeric strategy resulted in P3-1, a potent inhibitor of amyloid-β 42. Evidenced by both in vivo and in vitro experiments, its potential for contributing to the early detection and treatment of Alzheimer's Disease was demonstrated. Furthermore, the investigation of cyclic γ-AA peptide library was pursued as an efficient strategy for uncovering bioactive molecules. Two compounds, P4-1, and P4-2, identified from the macrocyclic combinatorial library, displayed a remarkable binding affinity towards Prostaglandin E2 receptor 2, marking a significant stride towards the development of potential therapeutics."]},{"key":"dc:title","label":"Title","values":["Development and application of γ-AA peptide on enzyme mimetic and biomolecular agents"]}]}],"canonical_facts":{"dc:contributor":["Jianfeng Cai, Ph.D.","Feng Cheng, Ph.D.","Kirpal Bisht, Ph.D.","Wayne Guida, Ph.D."],"dc:creator":["Gu, Meng"],"dc:date":["2023-06-29T07:00:00Z"],"dc:description":["This dissertation investigates the multifaceted utility of γ-AA peptides in various biological contexts, highlighting their capability in mimicking bioactive proteins, facilitating novel drug discovery, and obstructing protein-protein interactions. Initially, we introduced the design of an ingenious γ-AA peptide scaffold that replicates the hydrolysis capabilities of natural enzymes, with the intention to overcome their stability limitations. Notably, the designed catalyst exhibited excellent esterase activity with the coordination of Zn2+. Subsequently, optimization of a linear γ-AA peptide compound through a dimeric strategy resulted in P3-1, a potent inhibitor of amyloid-β 42. Evidenced by both in vivo and in vitro experiments, its potential for contributing to the early detection and treatment of Alzheimer's Disease was demonstrated. Furthermore, the investigation of cyclic γ-AA peptide library was pursued as an efficient strategy for uncovering bioactive molecules. Two compounds, P4-1, and P4-2, identified from the macrocyclic combinatorial library, displayed a remarkable binding affinity towards Prostaglandin E2 receptor 2, marking a significant stride towards the development of potential therapeutics."],"dc:identifier":["https://digitalcommons.usf.edu/etd/10781"],"dc:subject":["Enzyme-like catalyst","Hydrolysis","Alzheimer’s disease","Aβ inhibition","macrocyclic combinatorial library","Chemistry"],"dc:title":["Development and application of γ-AA peptide on enzyme mimetic and biomolecular agents"],"thesis:degree_discipline":["Chemistry"],"thesis:degree_level":["Dissertation","Ph.D."],"thesis:degree_name":["Doctor of Philosophy (Ph.D.)"],"thesis:institution_name":["University of South Florida"]},"updated_at":"2026-11-19T08:50:05Z"}